РЕМДЕСИВИР
Active substance: remdesivir
лиофилизат для приготовления концентрата для приготовления раствора для инфузий, 100 мг, 100 мг (original in Russian, GRLS)
RussiaActive
Marketing holder: Акционерное общество "Р-Фарм" (АО "Р-Фарм")
Verified 2026-10-09 · GRLS (Russian state register)
Analogues in other countries- Source: GRLS (Russian state register)
- Countries with the substance registered: 3
Composition
Analogues by country
Import and control
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c3-3208-7cdc-8e94-17dc84fd8fec,01a120c3-4c15-789e-8fe0-ee32b0438b3c,01a120c3-6ba6-71d1-b04a-ea5a623095b4,01a120c3-7bac-74f1-a2a3-b311341f1197,01a120c3-b55b-7c5b-97b3-06fca4fa3fb5;count=8 · valid from 2026-10-09 · verified 2026-10-09
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-87b5-74e4-94cd-758083d9ed39;count=1 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- ЛП-007694
- Registration status
- Active
- Dispensing
- Prescription only
- Release forms
- лиофилизат для приготовления концентрата для приготовления раствора для инфузий, 100 мг, 100 мг - флаконы - пачки картонные - По рецепту; (original in Russian, GRLS)
Sources
- product · GRLS (Russian state register) · ЛП-007694 · Verified 2026-10-09
- registration_status · GRLS (Russian state register) · ЛП-007694 · Verified 2026-10-09
- ingredients.0 · GRLS (Russian state register) · ЛП-007694 · Verified 2026-10-09